CONTROL-RA will investigate how study drug, VIB4920, affects control of rheumatoid arthritis.
BEAT-MS will compare autologous hematopoietic stem cell transplant (AHSCT) to the most effective standard treatment in MS.
The REVEAL Study will determine whether an experimental therapy can repigment the skin in vitiligo.